| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.37 | 0.2 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |